Correction
Accepted on 04 Nov 2025
Mechanistic insights into IL-1β-mediated progression of tendinopathy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Type at least 3 characters
1,259 articles
Original Research
Published on 04 Nov 2025
AIMing for survival: The impact of the free and total AIM concentration in septic patients
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1685119
- 236 views
Mini Review
Published on 04 Nov 2025
Roles of cytokine storm in sepsis progression: biomarkers, and emerging therapeutic strategies
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1696366
- 310 views
Perspective
Accepted on 03 Nov 2025
Regulatory T Cell Transdifferentiation as a Driver of Obesity and Diabetes
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Systematic Review
Published on 03 Nov 2025
CD137 in tuberculosis: a scoping review of an emerging immune checkpoint at the crossroads of diagnosis, prognosis, and therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1682269
- 897 views
Review
Published on 31 Oct 2025
Mechanistic insights into IL-1β-mediated progression of tendinopathy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1657285
- 533 views
Original Research
Accepted on 28 Oct 2025
SPHK1-Mediated M2 Macrophage Polarization Drives TGF-β1-Dependent Thrombus Fibrosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Review
Accepted on 27 Oct 2025
The Pivotal Role of Cytokines in Liver Disease Pathogenesis and Therapeutic Potential
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 223 views
Mini Review
Accepted on 27 Oct 2025
Cytokine Networks and Therapeutic Advances in Systemic Lupus Erythematosus
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 245 views
Mini Review
Published on 24 Oct 2025
The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1691988
- 859 views
Original Research
Published on 23 Oct 2025
Disrupted macrophage autophagy as a driver of cell death and LPS-induced lethal shock in systemic inflammation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1610033
- 1,519 views
Original Research
Accepted on 22 Oct 2025
Human Spinal Enthesis Comparative Biology of IL-17F and IL-17A Reveals Greater T-cell IL-17F Induction and IL-23 Regulation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 460 views
Original Research
Accepted on 22 Oct 2025
IL-6 as an integrative biomarker of residual inflammation and visceral adiposity in psoriasis: a VAI threshold-dependent model
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 458 views
Opinion
Published on 22 Oct 2025
Reframing chronic wound therapy: from growth factor delivery to regenerative immuno-engineering
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1683591
- 647 views
Original Research
Published on 22 Oct 2025
Serum IL-17F as a biomarker of infection-independent cirrhosis progression
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1671288
- 920 views
Original Research
Accepted on 21 Oct 2025
Interleukin-6 levels and their haplotypes are associated with serological autoantibodies status and clinical activity in rheumatoid arthritis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 422 views